Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective.

ABSTRACT: Cell-based therapies have been making great advances toward clinical reality. Despite the increase in trial activity, few therapies have successfully navigated late-phase clinical trials and received market authorization. One possible explanation for this is that additional tools and technologies to enable their development have only recently become available. To support the safety evaluation of cell therapies, the Health and Environmental Sciences Institute Cell Therapy-Tracking, Circulation and Safety Committee, a multisector collaborative committee, polled the attendees of the 2017 International Society for Cell & Gene Therapy conference in London, UK, to understand the gaps and needs that cell therapy developers have encountered regarding safety evaluations in vivo. The goal of the sur

SUBMITTER: Helfer BM 

PROVIDER: S-EPMC9344904 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature